SQ vs VTGN
SQ (SQ) versus VistaGen Therapeutics Inc (VTGN) — a side-by-side from cached financials, not a winner call.
SQ (SQ) common stock.
VistaGen Therapeutics Inc (VTGN) is a biotechnology company listed on NASDAQ.
SQ does not have a complete income-statement cache yet.
Latest reported VTGN revenue for 2023-03-31 was $176.0K. Net income was -$12.2M. VTGN currently screens at market cap $28.1M.
VTGN currently screens at market cap $28.1M.
Not investment advice. Open the SQ and VTGN stock pages for the full models.
Not investment advice.